Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
Aethlon Hemopurifier Effective in Capturing West Nile Virus
May 23rd, 2008
Aethlon Medical, Inc. (OTCBB:AEMD) announced that pre-clinical studies have documented that the Aethlon Hemopurifier(R) is effective in capturing circulating West Nile Virus (WNV). The study data further supports the potential use of the Hemopurifier(R) as a broad-spectrum treatment against viral pathogens, whether naturally occurring, or purposely released as biological weapons of mass destruction. During in vitro studies, high concentrations of WNV (approximately 700 thousand WNV/ml) were depleted from cell culture fluids when circulated through the Hemopurifier(R). The study data indicated that the Hemopurifier(R) removed 53 percent of infectious WNV in the first four hours of the...
Source: Health Business Week (2008-05-23)
|
